Company intelligence / Profile preview

Akaal Pharmacy

Shepparton, Victoria, Australiapc.go.tz ↗
Ownership
Private
Employees
~27
Development stage
Commercial
01

Overview

Akaal Pharma has completed recruitment for a Phase 2 clinical trial of topical AKP‑119 in atopic dermatitis with pruritus. Previous Phase 1a/1b studies showed safety and efficacy signals in atopic dermatitis and psoriasis. Lead candidates Takp‑119 and Oakp‑11 are differentiated S1P₁ modulators with high selectivity, strong activity, minimal lymphopenia, cardiovascular safety, and favorable PK profile.

Top-line data from the ongoing Phase 2 study expected Q3/Q4 of 2024.

Preclinical programs target neuropathic pain and autoimmune skin diseases.

The company holds patents on S1P receptor modulators for autoimmune disease applications.

Pipeline breadth includes at least four programs across various stages targeting immune-mediated conditions.

No commercialized products as of June 2025.

Therapeutic areas
GastroenterologyDermatologyImmunologyNeurology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Akaal Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akaal Pharmacy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call